Social Media Ideas for Jnj

Johnson & Johnson (JNJ) Dividend Stock Analysis

Linked here is a detailed quantitative analysis of Johnson & Johnson (JNJ). Below are some highlights from the above linked analysis: Company Description: Johnson &amp...

Johnson & Johnson (JNJ) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript

Johnson & Johnson: An Excellent Portfolio Option To Barbell AI, Initiate Buy Rating

J&J gets naming rights to the Johnson & Johnson Exchange at the New Jersey Innovation Hub, Powered by Portal Inn...

Portal Innovations, in partnership with the New Brunswick Development Corporation (DEVCO) and HELIX, announced May 19 that Johnson & Johnson received naming rights to the Johns...

Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

Bristol Myers Squibb leans on specialty medicines and a discounted valuation, while Johnson & Johnson boasts industry-leading margins and cash flow.

Jim Cramer Explains Johnson & Johnson’s (JNJ) Shares Have Gained

Two Paths to Growth: Johnson & Johnson vs AbbVie

J&J seeks expanded use for drug after positive head and neck cancer study

Why Johnson & Johnson Might Be the Smartest Dividend King to Buy in Today's Market

Johnson & Johnson sells products that are necessities, not just nice-to-haves.

Johnson & Johnson: Stronger Fundamentals, But Too Much Optimism

Johnson & Johnson (JNJ): Focused on Cancer and Neuroscience as a Top Dividend Aristocrat Stock to Buy

Why Johnson & Johnson (JNJ) Still Fits a Defensive Growth Case

Dividend Kings In Focus: Johnson & Johnson

Updated on July 8th, 2026 by Nathan Parsh Only the best companies can increase dividends through multiple recessions. The Dividend Kings are a group of stocks that have increased t...

Johnson & Johnson Nabs Naming Rights to New Brunswick’s HELIX Development

Johnson & Johnson is putting its name on the first phase of New Brunswick’s HELIX development, where a new innovation hub will support early-stage life sciences startups with l...

Johnson & Johnson (JNJ) Beats Lawsuit Alleging that Talc caused Three Women’s Cancer

Johnson & Johnson announces $1B Firefly Bio acquisition to expand oncology pipeline

New Brunswick-based Johnson & Johnson has entered into a definitive agreement to acquire Firefly Bio, Inc., a biotechnology company advancing its proprietary Firelink degrader...

J&J study suggests earlier use of prostate cancer drug improves outcomes

J&J axes eye disease gene therapy after key phase 2b readout

Johnson & Johnson has stopped development of an eye disease gene therapy after reviewing data from one of its key readouts for 2026.

Why We Increased The Position In Johnson & Johnson

J&J makes $1B upfront bet on emerging DAC space by netting Firefly Bio

Johnson & Johnson has paid $1 billion upfront to buy itself a degrader antibody conjugate platform via the acquisition of Firefly Bio.

3 No-Brainer Dividend Stocks to Buy Right Now

AbbVie, J&J, and Pfizer are all reliable income plays in this choppy market.

J&J beats lawsuit alleging that talc caused three women’s cancer

Johnson & Johnson to build $1B Florida distribution hub

J&J's billion-dollar infusion will expand a distribution facility in Jacksonville to increase production capacity for Acuvue products and strengthen U.S. operations. The post J...

<![CDATA[Pharma M&A Roundup: Gilead Sciences Expands Collaboration with World Health Organization, Johnson &...